The $4 trillion healthcare industry is under intense focus and is rapidly changing, right here, right now. Never has there been a better opportunity .. Read more to do so much good for more people than ever before. To address these changes, healthcare leaders are moving towards value-based models that allow for more easily accessible treatment that puts the patient right at the epicenter of care. Megan Blewett is an investor at Venrock focused on the biotech and pharmaceutical spaces. Megan is also a board observer at Federation Bio and Prothelia. Prior to Venrock, Megan earned a PhD in chemistry as a Hertz Fellow and NSF Fellow with Ben Cravatt at The Scripps Research Institute. Megan has been named to Business Insider’s Under 40 in Biotech and to the Forbes 30 under 30 list for Healthcare.
- Share your Experience